{"name": "Circassia",
 "permalink": "circassia",
 "crunchbase_url": "http://www.crunchbase.com/company/circassia",
 "homepage_url": "http://www.circassia.co.uk/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "Charlesswingland@circassia.co.uk",
 "phone_number": "+44 (0)1865 784574",
 "description": "",
 "created_at": "Sat Dec 12 06:24:29 UTC 2009",
 "updated_at": "Wed Apr 20 02:28:56 UTC 2011",
 "overview": "\u003Cp\u003ECircassia is a specialty biopharmaceutical company focused on developing a new class of T-cell vaccines designed to treat allergies and combat organ transplant rejection. The Company\u00e2\u20ac\u2122s most advanced allergy T-cell vaccine is entering late-stage development, having successfully completed a number of phase II clinical studies.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       47],
      "assets/images/resized/0006/9420/69420v1-max-150x150.jpg"],
     [[207,
       65],
      "assets/images/resized/0006/9420/69420v1-max-250x250.jpg"],
     [[207,
       65],
      "assets/images/resized/0006/9420/69420v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Steven",
      "last_name": "Harris",
      "permalink": "steven-harris",
      "image": null}},
   {"is_past": false,
    "title": "Deputy Chairman and General Counsel",
    "person":
     {"first_name": "Charles",
      "last_name": "Swingland",
      "permalink": "charles-swingland",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a3113M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020091211e5ce000p1\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Cat Allergy Treatment Co. Circassia Nabs $25M, Takes Gander At Dander  ",
    "raised_amount": 15250000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Imperial Innovations",
         "permalink": "imperial-innovations",
         "image":
          {"available_sizes":
            [[[65,
               150],
              "assets/images/resized/0004/6361/46361v1-max-150x150.jpg"],
             [[108,
               250],
              "assets/images/resized/0004/6361/46361v1-max-250x250.jpg"],
             [[193,
               445],
              "assets/images/resized/0004/6361/46361v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "INVESCO Private Capital",
         "permalink": "invesco-private-capital",
         "image":
          {"available_sizes":
            [[[58,
               45],
              "assets/images/resized/0002/9319/29319v1-max-150x150.png"],
             [[58,
               45],
              "assets/images/resized/0002/9319/29319v1-max-250x250.png"],
             [[58,
               45],
              "assets/images/resized/0002/9319/29319v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lansdowne Partners",
         "permalink": "lansdowne-partners",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0007/1444/71444v1-max-150x150.jpg"],
             [[193,
               68],
              "assets/images/resized/0007/1444/71444v1-max-250x250.jpg"],
             [[193,
               68],
              "assets/images/resized/0007/1444/71444v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.fiercebiotech.com/story/circassia-lands-98m-venture-round-it-plots-ph3-trials/2011-04-19?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Circassia lands $98M venture round as it plots Ph3 trials",
    "raised_amount": 98000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 4,
    "funded_day": 19,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Magdalen Centre",
    "address2": "The Oxford Science Park",
    "zip_code": "OX4 4GA",
    "city": "Oxford ",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0006/9419/69419v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0006/9419/69419v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0006/9419/69419v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}